The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence.
 
Elisabeth Livingstone
Honoraria - Bristol-Myers Squibb; Medac; Novartis; Pierre Fabre; Sanofi; Sun Pharma
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medac; Pierre Fabre; Sun Pharma
 
Andrea Forschner
Honoraria - Bristol-Myers Squibb; CeGaT; MSD; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche Pharma AG
Research Funding - Stiftung Immunonkologie/Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche
 
Jessica Cecile Hassel
Honoraria - Almirall Hermal GmbH; Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Roche Pharma AG; Sanofi; Sun Pharma
Consulting or Advisory Role - MSD; Sanofi Aventis GmbH; Sun Pharma
Research Funding - 4SC (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Idera (Inst); Immunocore (Inst); Iovance Biotherapeutics (Inst); Nektar (Inst); Novartis (Inst); Philogen (Inst); Pierre Fabre (Inst); Regeneron (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - 4SC
 
Lena M. Wulfken
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Novartis
 
Friedegund Elke Meier
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche; Sanofi
 
Peter Mohr
Honoraria - Beiersdorf; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
 
Katharina C. Kähler
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Bastian Schilling
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer/EMD Serono; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi Aventis GmbH
Research Funding - Novartis (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche
 
Carmen Loquai
Consulting or Advisory Role - Almirall Hermal GmbH (Inst); Biontech (Inst); Bristol-Myers Squibb (Inst); Kyowa Kirin International (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Almirall Hermal GmbH (Inst); Biontech (Inst); Bristol-Myers Squibb (Inst); Kyowa Kirin International (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Sun Pharma (Inst)
 
Carola Berking
Honoraria - Almirall Hermal GmbH; Bristol-Myers Squibb; Immunocore; InflarxGmbH; LEO Pharma; MSD; Novartis; Pierre Fabre; Pierre Fabre; Sanofi/Aventis
Consulting or Advisory Role - Almirall Hermal GmbH; Bristol-Myers Squibb; Immunocore; MSD; Novartis; Roche; Sanofi/Aventis; Sanofi/Regeneron
 
Svea Hüning
Honoraria - Bristol Myers Squibb
Consulting or Advisory Role - Kyowa Kirin; MSD; Sun Pharma
Travel, Accommodations, Expenses - Pierre Fabre
 
Julia Eckardt
No Relationships to Disclose
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche; Sun Pharma
 
Lydia Reinhardt
No Relationships to Disclose
 
Bernd Kowall
No Relationships to Disclose
 
Wolfgang Galetzka
No Relationships to Disclose
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Philogen; Regeneron; Replimune; Roche; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Philogen; Regeneron; Replimune; Roche; Sanofi/Aventis
Research Funding - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche; Sanofi/Aventis
 
Lisa Zimmer
Stock and Other Ownership Interests - Bayer
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi; Sun Pharma
 
Dirk Schadendorf
Honoraria - 4SC; Amgen; Array BioPharma; Bristol-Myers Squibb; Daiichi Sankyo Japan; Immunocore; InflarxGmbH; LabCorp; Merck Serono; Merck Sharp & Dohme; Nektar; NeraCare GmbH; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Replimune; Roche/Genentech; Sandoz; Sanofi/Regeneron; Sun Pharma; Ultimovacs
Consulting or Advisory Role - 4SC; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; NEKTAR; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi/Regeneron
Research Funding - Amgen (Inst); Array BioPharma/Pfizer (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi/Regeneron
 
Georg Lodde
Travel, Accommodations, Expenses - Sun Pharma